Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RebiSmart Suitability for Rebif Self-Injection in RMS
NCT00735007Phase 3Completed
- Sponsor
- EMD Serono
- Start
- Jul 2008
- Primary completion
- Jan 2009
- Modality
- Cytokines & Interferons
- Countries
- 6
01
Overview
A Phase 3 trial of interferon beta in multiple sclerosis (MS), sponsored by EMD Serono. Started Jul 2008; status: completed.
02
Drugs
interferon beta
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00735007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00735007.